Best in Biotech 14 Oct 2024 Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates …million ($13 million) in a series A funding round, allowing it to continue the development of BIOX-101 through to the end of phase 2a trials. Celtic Biotech Leading biomimicry drug… October 14, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Inside Labiotech 17 Mar 2017 Why is Sofinnova’s Rafaèle Tordjman reading Labiotech.eu? …at Sofinnova Partners, one of the most successful European biotech VCs. This interview has just been lightly edited for grammar. Why do you read Labiotech.eu? Labiotech.eu is very interesting, not… March 17, 2017 - 2 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
Inside Labiotech 14 Feb 2019 Say Hello to The Brand-New Labiotech.eu, Our Biggest Product Redesign Since We Launched 💥 …such a large revamp. We launched the first version of Labiotech.eu in September 2014 (https://www.labiotech.eu/inside-labiotech/public-launch-labiotech-eu-betahaus-berlin/), and wow, this gives me goosebumps to see now. 😇 To save time and resources… February 14, 2019 - 4 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
Inside Labiotech 10 Jun 2022 Beyond Biotech – the new Labiotech podcast Labiotech.eu has just gone global with its coverage, and now we are gearing up for the first Labiotech.eu podcast. According to Spotify, in 2021 there were 1.2 million podcasts launched…. June 10, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jul 2025 Seven biotechs in Belgium making leaps in the clinic Belgium, the land of chocolate, beer, and waffles, has a thriving biotech and life science sector, with more than 300 biopharmaceutical companies operating in the country. The country is positioned… July 22, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2024 Ten NK cell therapy companies to look out for this year …monoclonal antibody rituximab, had a 57.1% Objective Response Rate (ORR) in seven patients. Last year, the biotech received the Immunology Innovation of the Year award in the 2023 BioTech Breakthrough… January 11, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 6 Jun 2024 Eight biotech companies advancing the field of siRNA Small interfering RNA (siRNA) carries great promise in the biotechnology industry. As an essential component of the RNA interference (RNAi) pathway, siRNA works by degrading target messenger RNA (mRNA) molecules,… June 6, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Aug 2023 Five North Carolina biotech companies making their mark …for their bustling biotech scenes. There are more than 810 life science companies situated in North Carolina, with some of the biggest names in biotech having manufacturing sites there, including… August 30, 2023 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2025 XOMA Royalty’s acquisition of Turnstone Biologics: what do royalty deals offer the biopharma industry? …other royalty aggregators, according to Sitko. They provide money to biotechs in exchange for at-risk, future payments from partnered programs. “A biotech company partners with a pharma, and the biotech… July 11, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2024 Special Olympics: How is biotechnology revolutionizing sports performance worldwide? Biotechnology can be used to improve athletic performance and recovery in sports, from genetic profiling, stem cells, and wearable technologies. As the 2024 Olympic Games are approaching, we take a… July 1, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
2024 biotech deals tracker: the latest partnerships and M&A Visit our 2025 biotech deals tracker for the newest deals. Explore the pulse of biotech deals on our dedicated page, featuring only the most notable news sorted by top pharmaceutical… March 7, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
In Depth 20 Oct 2022 Opportunities and challenges for cell and gene therapy investments …a lot of optimism regarding the European ecosystem, despite the fact that the funding conditions are very hard.” Image/Shutterstock Biotech will progress Amid the gloomy funding situation for biotech companies,… October 20, 2022 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email